M-CSF and IL-34 expression as indicators for growth in sporadic vestibular schwannoma

por de Vries, W. M., Briaire-de Bruijn, I. H., van Benthem, P. P. G., van der Mey, A. G. L., Hogendoorn, P. C. W.
Publicado 2018

Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways

por Cleton-Jansen, A-M, Anninga, J K, Briaire-de Bruijn, I H, Romeo, S, Oosting, J, Egeler, R M, Gelderblom, H, Taminiau, A H M, Hogendoorn, P C W
Publicado 2009

Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways

por Cleton-Jansen, A-M, Anninga, J K, Briaire-de Bruijn, I H, Romeo, S, Oosting, J, Egeler, R M, Gelderblom, H, Taminiau, A H M, Hogendoorn, P C W
Publicado 2009

Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells

por van Oosterwijk, J G, van Ruler, M A J H, Briaire-de Bruijn, I H, Herpers, B, Gelderblom, H, van de Water, B, Bovée, J V M G
Publicado 2013

Targeting survivin as a potential new treatment for chondrosarcoma of bone

por de Jong, Y, van Oosterwijk, J G, Kruisselbrink, A B, Briaire-de Bruijn, I H, Agrogiannis, G, Baranski, Z, Cleven, A H G, Cleton-Jansen, A-M, van de Water, B, Danen, E H J, Bovée, J V M G
Publicado 2016